Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

TaiwanJ reports positive data from Phase II JKB-122 trial

Micrograph of autoimmune hepatitis. Credit: Nephron.

  • TaiwanJ Pharmaceuticals

Go Top